Moderna Applies For FDA Emergency Use Authorization For Coronavirus Vaccine

Drugmaker Moderna says it has applied to the Food and Drug Administration for emergency use authorization for its coronavirus vaccine. It says data bolster its case the vaccine is safe and effective. ARI SHAPIRO, HOST: Today, the drug company Moderna asked the Food and Drug Administration to clear its experimental COVID-19 vaccine for emergency use.…Continue Reading

Moderna to Ask FDA to Authorize Vaccine

Moderna Inc. said it would ask U.S. and European health regulators Monday to authorize use of its Covid-19 vaccine, after it was shown to be 94.1% effective in a full analysis of a pivotal study. The timing keeps the vaccine on track to become possibly the second to go into use in the U.S. by…Continue Reading

Moderna CEO Says COVID Vaccine Ready to Roll Out Within Day of FDA Approval in December

The boss of biotech company Moderna has said its COVID vaccine could roll out to Americans within 24 hours of government approval.Stéphane Bancel, CEO of the Massachusetts-based company, told Fox Business host Maria Bartiromo today the firm applied for Emergency Use Authorization from the Food and Drug Administration (FDA)—and authorization could come next month.Earlier today,…Continue Reading

How the Moderna Covid-19 vaccine stacks up against Pfizer’s

On the morning of Nov. 16, American pharma company Moderna released results of a key study for its experimental coronavirus vaccine. The results were promising, with an efficacy rate of 94.5%. At the time of publication, Moderna’s stock was up about 8%.Moderna is now the second company to report promising clinical trial results for a…Continue Reading

Moderna says its coronavirus vaccine is nearly 95% effective

Moderna said Monday that its coronavirus vaccine candidate is 94.5% effective in fighting the virus, per an initial analysis released by the company.Why it matters: The Moderna vaccine — alongside Pfizer’s similarly effective candidate — provides another dash of hope that the pandemic currently raging across the world could be tamed by next year.The state of play:…Continue Reading

Moderna says its covid-19 vaccine is nearly 95% effective

More good news: US drug company Moderna announced today that early trials of its covid-19 vaccine show that it is 94.5% effective. The news comes hot on the heels of a similar announcement last week from Pfizer, which reported that its own covid-19 vaccine was more than 90% effective. With covid-19 having killed 1.3 million…Continue Reading

Moderna Might Seek Government OK for Vaccine in December

Pharmaceutical company Moderna has enrolled all 30,000 volunteers in its coronavirus vaccine clinical trial and might seek emergency use authorization for the vaccine as early as December if the trials prove it’s safe. Moderna Chief Executive Stéphane Bancel, speaking at The Wall Street Journal’s annual Tech Live conference, said that timetable would not hold up…Continue Reading

Moderna Vaccine Produces Immune Response in Patients

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Every person who received Moderna’s COVID-19 vaccine, mRNA-1273, developed an immune response to the virus that causes it, the company says in a news release. Researchers also reported some side effects in the 45 people in the phase I study, but…Continue Reading

Moderna Announces Progress in Early COVID Vaccine Trials

Tthe headquarters of Moderna Inc, which is developing a vaccine against the coronavirus, in Cambridge, Mass., May 18, 2020 (Brian Snyder/Reuters) Biotech company Moderna announced on Tuesday that a potential coronavirus vaccine has produced a “robust” immune response in all patients participating in early vaccine trials. The trials centered on three groups of 45 patients,…Continue Reading